Advanced Biochemical Thailand introduces new EPINITY brand of epichlorohydrin, a biobased material; product is suitable for a range of downstream applications including protective coatings, adhesives, advanced composites, paper, water treatment chemicals

August 9, 2022 (press release) –

Advanced Biochemical Thailand (ABT) has today launched its new product brand, EPINITY™ with a new website. EPINITY™ is the new brand name for ABT’s Epichlorohydrin (ECH), a bio-based, drop-in, and competitive ECH for use in a wide range of downstream industries.

Launching EPINITY™ is a key milestone for ABT to represent the company’s long experience in the reliable supply of high quality bio-based ECH and to emphasise its position as a pioneer in supporting its customers and downstream users to achieve their challenging carbon reduction targets to meet Net Zero carbon emission goals.

Mr Masaki Takahashi, Managing Director said, “Building on ten years of ECH production, the new EPINITY™ brand confirms ABT’s position as a leading producer of bio-based ECH and takes us forward into the next decade, a decade which is critical to the future of our planet. EPINITY™ is best-in-class bio-based ECH and I am proud of the ABT team which has worked tirelessly to launch this new brand and website.”

EPINITY™ is mainly used as a precursor to epoxy resins, with uses in protective coatings, electronic components, adhesives and advanced composite materials. Other applications include paper and water treatment chemicals, mild surfactants in personal care and fine chemical applications.

Media contact
Kathryn Sheridan
Sustainability Consult
ks@sustainabilityconsult.com

About Advanced Biochemical Thailand (ABT)
ABT produces bio-based Epichlorohydrin (ECH) based on natural, renewable vegetable glycerine. ABT has operated its world-class manufacturing unit in the Map Ta Phut Industrial Estate since February 2012. ABT is wholly-owned by AGC Vinythai Public Company Limited (AVT) and both companies strongly adhere to sustainability and social responsibility commitments.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.